K-V Bankruptcy May Hurt FDA's Unapproved Drug Initiative
K-V Pharmaceutical Co. claims a U.S. Food and Drug Administration decision to allow cheap compounded drugs to compete with its newly approved brand-name drug drove it to bankruptcy, a move experts...To view the full article, register now.
Already a subscriber? Click here to view full article